Anderson-Fabry Disease: A Cardiomyopathy That Can Be Cured

被引：0

作者：

Anastasakis, Aris ^{[1
]}

Sevdalis, Elias ^{[1
]}

Papatheodorou, Efstathios ^{[1
]}

Stefanadis, Christodoulos ^{[1
]}

机构：

[1] Univ Athens, Dept Cardiol 1, Heart Ctr Young & Athletes EKKAN, Unit Inherited Cardiovasc Dis, Athens, Greece

来源：

HELLENIC JOURNAL OF CARDIOLOGY | 2011年 / 52卷 / 04期

关键词：

Anderson-Fabry disease; hypertrophic cardiomyopathy; enzyme replacement therapy; Fabry; ENZYME REPLACEMENT THERAPY; ALPHA-GALACTOSIDASE-A; LEFT-VENTRICULAR HYPERTROPHY; CARDIAC MANIFESTATIONS; MYOCARDIAL-PERFUSION; ATYPICAL VARIANT; AGALSIDASE-BETA; ONSET; PREVALENCE; STORAGE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：316 / 326

页数：11

共 78 条

[1] Elevated globotriaosylsphingosine is a hallmark of Fabry disease [J].

Aerts, Johannes M. ;

Groener, Johanna E. ;

Kuiper, Sijmen ;

Donker-Koopman, Wilma E. ;

Strijland, Anneke ;

Ottenhoff, Roelof ;

van Roomen, Cindy ;

Mirzaian, Mina ;

Wijburg, Frits A. ;

Linthorst, Gabor E. ;

Vedder, Anouk C. ;

Rombach, Saskia M. ;

Cox-Brinkman, Josanne ;

Somerharju, Pentti ;

Boot, Rolf G. ;

Hollak, Carla E. ;

Brady, Roscoe O. ;

Poorthuis, Ben J. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (08) :2812-2817

[2]

Anastasakis A, 2001, CARDIOLOGY TXB

[3]

[Anonymous], 2001, METABOLIC MOL BASIS

[4] Cardiac and vascular hypertrophy in Fabry disease: Evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition [J].

Barbey, F ;

Brakch, N ;

Linhart, A ;

Rosenblatt-Velin, N ;

Jeanrenaud, X ;

Qanadli, S ;

Steinmann, B ;

Burnier, M ;

Palecek, T ;

Bultas, J ;

Hayoz, D .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (04) :839-844

[5] Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy [J].

Beer, Meinrad ;

Weidemann, Frank ;

Breunig, Frank ;

Knoll, Anita ;

Koeppe, Sabrina ;

Machann, Wolfram ;

Hahn, Dietbert ;

Wanner, Christoph ;

Strotmann, Jorg ;

Sandstede, Jorn .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10) :1515-1518

[6] Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease [J].

Bierer, Gregory ;

Balfe, David ;

Wilcox, William R. ;

Mosenifar, Zab .

JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 (04) :572-579

[7] Clinical benefit of enzyme replacement therapy in Fabry disease [J].

Breunig, F ;

Weidemann, F ;

Strotmann, J ;

Knoll, A ;

Wanner, C .

KIDNEY INTERNATIONAL, 2006, 69 (07) :1216-1221

[8] Restrictive cardiomyopathy secondary to Fabry's disease [J].

Cantor, WJ ;

Butany, J ;

Iwanochko, M ;

Liu, P .

CIRCULATION, 1998, 98 (14) :1457-1459

[9] Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy [J].

Chimenti, C ;

Pieroni, M ;

Morgante, E ;

Antuzzi, D ;

Russo, A ;

Russo, MA ;

Maseri, A ;

Frustaci, A .

CIRCULATION, 2004, 110 (09) :1047-1053

[10] MUTATION ANALYSIS IN PATIENTS WITH THE TYPICAL FORM OF ANDERSON-FABRY DISEASE [J].

DAVIES, JP ;

WINCHESTER, BG ;

MALCOLM, S .

HUMAN MOLECULAR GENETICS, 1993, 2 (07) :1051-1053

← 1 2 3 4 5 6 7 8 →